methylphenidate IR
Selected indexed studies
- Stimulants. (Child Adolesc Psychiatr Clin N Am, 2022) [PMID:35697391]
- Methylphenidate (OROS formulation). (CNS Drugs, 2001) [PMID:11524026]
- Are the effects of methylphenidate uncertain? (Ir J Psychol Med, 2018) [PMID:30124188]
_Worker-drafted node — pending editorial review._
Connections
methylphenidate IR is a side effect of
Sources
- Methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder. (2014) pubmed
- Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. (2021) pubmed
- Stimulants. (2022) pubmed
- Methylphenidate (OROS formulation). (2001) pubmed
- Are the effects of methylphenidate uncertain? (2018) pubmed
- Neurocognitive effects of switching from methylphenidate-IR to OROS-methylphenidate in children with ADHD. (2009) pubmed
- Switching from Methylphenidate-Immediate Release (MPH-IR) to Methylphenidate-OROS (OROS-MPH): A Multi-center, Open-label Study in Korea. (2011) pubmed
- Opioids for pain. (2018) pubmed
- Social adjustment and family function after drug switch from IR-methylphenidate to OROS-methylphenidate in patients with attention-deficit/hyperactivity disorder. (2018) pubmed
- Methylphenidate controlled-delivery capsules (EquasymXL, Metadate CD): a review of its use in the treatment of children and adolescents with attention-deficit hyperactivity disorder. (2006) pubmed